ProShares Ultra Nasdaq Biotechnology (BIB) Leverage/Terbalik
$112,06
▲ +2,26 (+2,05%)
Perubahan 1 hari
$62,72 – $126,40
Rentang 52 minggu
Data kepemilikan belum tersedia untuk dana ini.
BIB Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Performa per 2 Okt. 2026
| Periode | Imbal hasil harga | Imbal hasil total |
|---|---|---|
| 1M | ▼ -9,84% | ▼ -9,78% |
| 3M | ▲ +2,77% | ▲ +2,84% |
| 6M | ▲ +34,28% | ▲ +34,37% |
| YTD | ▲ +37,63% | ▲ +37,74% |
| 1Y | ▲ +73,21% | ▲ +73,64% |
| 3Y | ▲ +135,47% | ▲ +142,03% |
| 5Y | ▲ +20,16% | ▲ +23,54% |
| Maks | ▲ +1362,31% | ▲ +1406,10% |
Volatilitas 1T42,75%
Volatilitas 3Y41,86%
Penurunan Maksimum 3Y
-45,99%
Beta 3Y0,84
Sharpe 1Y*1,50
Total pengembalian mengasumsikan dividen diinvestasikan kembali. Pengembalian tidak dibandingkan dengan indeks. * Rasio Sharpe dihitung dengan suku bunga bebas risiko 0%.
Aliran dana (dilaporkan SEC)
Bulan lalu (Mei 2026)
-$4.8M
Kuartal berakhir Mei 2026
-$13.9M
12 bulan terakhir
-$12.0M
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Komposisi Penuh 267 saham
| Nama | CUSIP | Nilai | % | Saldo | Kategori | Negara |
|---|---|---|---|---|---|---|
| Rigel Pharmaceuticals, Inc. | 766559702 | $20K | 0,03 | 672 | EC | US |
| Aclaris Therapeutics, Inc. | 00461U105 | $20K | 0,03 | 4.459 | EC | US |
| Prothena Corp. plc | · | $20K | 0,03 | 1.989 | EC | IE |
| 4D Molecular Therapeutics, Inc. | 35104E100 | $19K | 0,03 | 1.885 | EC | US |
| Aquestive Therapeutics, Inc. | 03843E104 | $18K | 0,02 | 4.511 | EC | US |
| Allogene Therapeutics, Inc. | 019770106 | $18K | 0,02 | 8.308 | EC | US |
| Kyverna Therapeutics, Inc. | 501976104 | $18K | 0,02 | 2.112 | EC | US |
| Aura Biosciences, Inc. | 05153U107 | $18K | 0,02 | 2.349 | EC | US |
| Fulcrum Therapeutics, Inc. | 359616109 | $17K | 0,02 | 2.464 | EC | US |
| Upstream Bio, Inc. | 91678A107 | $17K | 0,02 | 1.997 | EC | US |
| Kamada Ltd. | · | $17K | 0,02 | 2.134 | EC | IL |
| Pacific Biosciences of California, Inc. | 69404D108 | $17K | 0,02 | 11.163 | EC | US |
| First Tracks Biotherapeutics, Inc. | 337185102 | $16K | 0,02 | 1.023 | EC | US |
| Neurogene, Inc. | 64135M105 | $16K | 0,02 | 571 | EC | US |
| C4 Therapeutics, Inc. | 12529R107 | $16K | 0,02 | 3.609 | EC | US |
| Evolus, Inc. | 30052C107 | $16K | 0,02 | 2.397 | EC | US |
| Lakefront Biotherapeutics NV | 36315X101 | $16K | 0,02 | 548 | EC | BE |
| Contineum Therapeutics, Inc. | 21217B100 | $15K | 0,02 | 1.124 | EC | US |
| OmniAb, Inc. | 68218J103 | $14K | 0,02 | 5.322 | EC | US |
| Altimmune, Inc. | 02155H200 | $14K | 0,02 | 4.631 | EC | US |
| Enanta Pharmaceuticals, Inc. | 29251M106 | $14K | 0,02 | 1.072 | EC | US |
| Vanda Pharmaceuticals, Inc. | 921659108 | $14K | 0,02 | 2.186 | EC | US |
| Larimar Therapeutics, Inc. | 517125100 | $14K | 0,02 | 4.014 | EC | US |
| Autolus Therapeutics plc | 05280R100 | $14K | 0,02 | 7.414 | EC | GB |
| Lexeo Therapeutics, Inc. | 52886X107 | $14K | 0,02 | 2.697 | EC | US |
| Immuneering Corp. | 45254E107 | $14K | 0,02 | 2.387 | EC | US |
| Lyell Immunopharma, Inc. | 55083R203 | $14K | 0,02 | 787 | EC | US |
| Atea Pharmaceuticals, Inc. | 04683R106 | $13K | 0,02 | 2.889 | EC | US |
| Puma Biotechnology, Inc. | 74587V107 | $13K | 0,02 | 1.879 | EC | US |
| Cabaletta Bio, Inc. | 12674W109 | $13K | 0,02 | 3.557 | EC | US |
| REGENXBIO, Inc. | 75901B107 | $13K | 0,02 | 1.873 | EC | US |
| Keros Therapeutics, Inc. | 492327101 | $13K | 0,02 | 1.125 | EC | US |
| Editas Medicine, Inc. | 28106W103 | $12K | 0,02 | 3.611 | EC | US |
| SIGA Technologies, Inc. | 826917106 | $12K | 0,02 | 2.646 | EC | US |
| Rocket Pharmaceuticals, Inc. | 77313F106 | $12K | 0,02 | 4.013 | EC | US |
| Silence Therapeutics plc | 82686Q101 | $12K | 0,02 | 1.736 | EC | GB |
| Invivyd, Inc. | 00534A102 | $12K | 0,02 | 10.244 | EC | US |
| Neumora Therapeutics, Inc. | 640979100 | $11K | 0,02 | 6.176 | EC | US |
| Alpha Teknova, Inc. | 02080L102 | $11K | 0,01 | 1.981 | EC | US |
| Anavex Life Sciences Corp. | 032797300 | $10K | 0,01 | 3.426 | EC | US |
| Entrada Therapeutics, Inc. | 29384C108 | $10K | 0,01 | 1.416 | EC | US |
| AC Immune SA | · | $10K | 0,01 | 3.721 | EC | CH |
| Humacyte, Inc. | 44486Q103 | $9K | 0,01 | 7.136 | EC | US |
| Foghorn Therapeutics, Inc. | 344174107 | $9K | 0,01 | 2.165 | EC | US |
| Codexis, Inc. | 192005106 | $9K | 0,01 | 3.341 | EC | US |
| LENZ Therapeutics, Inc. | 52635N103 | $9K | 0,01 | 1.158 | EC | US |
| Coherus Oncology, Inc. | 19249H103 | $9K | 0,01 | 5.525 | EC | US |
| Quantum-Si, Inc. | 74765K105 | $9K | 0,01 | 7.230 | EC | US |
| Voyager Therapeutics, Inc. | 92915B106 | $8K | 0,01 | 2.179 | EC | US |
| Sagimet Biosciences, Inc. | 786700104 | $8K | 0,01 | 1.147 | EC | US |
Dividen 13 pembayaran
0,20%Imbal hasil TTM
$0,23Pembayaran TTM / saham
Kuartalan
(est.)
| Tanggal ex-dividen | Jumlah / saham |
|---|---|
| 23 Sep. 2026 | $0,0830 |
| 25 Maret 2026 | $0,0070 |
| 24 Des. 2025 | $0,1350 |
| 24 Sep. 2025 | $0,1810 |
| 25 Juni 2025 | $0,1710 |
| 26 Maret 2025 | $0,1310 |
| 23 Des. 2024 | $0,3960 |
| 25 Sep. 2024 | $0,1530 |
| 26 Juni 2024 | $0,2650 |
| 20 Maret 2024 | $0,0400 |
| 20 Des. 2023 | $0,0380 |
| 22 Des. 2022 | $0,0200 |
| 21 Sep. 2010 | $0,0110 |
Pemilik institusional (13F) 22 pengaju
Institusi yang melaporkan kepemilikan ETF ini dalam Formulir SEC 13F triwulanan mereka. Hanya posisi long; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
| Institusi | Nilai | % dari 13F yang dilacak | Saham | Tipe | Per tanggal |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $785.973 | 21,94% | 7.802 | Saham | 30 Juni 2026 |
| Capital Investment Advisors, LLC | $599.013 | 16,72% | 5.946 | Saham | 30 Juni 2026 |
| Kaizen Financial Strategies | $535.554 | 14,95% | 5.315 | Saham | 30 Juni 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $413.034 | 11,53% | 4.100 | Opsi beli | 30 Juni 2026 |
| Palumbo Wealth Management LLC | $402.960 | 11,25% | 4.000 | Saham | 30 Juni 2026 |
| CITADEL ADVISORS LLC | $302.220 | 8,44% | 3.000 | Opsi beli | 30 Juni 2026 |
| Jump Financial, LLC | $257.189 | 7,18% | 2.553 | Saham | 30 Juni 2026 |
| TOTH FINANCIAL ADVISORY CORP | $102.957 | 2,87% | 1.022 | Saham | 30 Juni 2026 |
| FRANKLIN RESOURCES INC | $70.115 | 1,96% | 696 | Saham | 30 Juni 2026 |
| PNC Financial Services Group, Inc. | $50.370 | 1,41% | 500 | Saham | 30 Juni 2026 |
| Ashton Thomas Private Wealth, LLC | $37.576 | 1,05% | 373 | Saham | 30 Juni 2026 |
| Truvestments Capital LLC | $12.593 | 0,35% | 125 | Saham | 30 Juni 2026 |
| Axiom Investment Management LLC | $5.037 | 0,14% | 50 | Saham | 30 Juni 2026 |
| Qube Research & Technologies Ltd | $4.936 | 0,14% | 49 | Saham | 30 Juni 2026 |
| SIMPLEX TRADING, LLC | $1.309 | 0,04% | 13 | Saham | 30 Juni 2026 |
| CHASE INVESTMENT COUNSEL CORP | $241 | 0,01% | 2.400 | Saham | 30 Juni 2026 |
| Rockefeller Capital Management L.P. | $201 | 0,01% | 2 | Saham | 30 Juni 2026 |
| MORGAN STANLEY | $131 | 0,00% | 1 | Saham | 30 Juni 2026 |
| UBS Group AG | $101 | 0,00% | 1 | Saham | 30 Juni 2026 |
| WELLS FARGO & COMPANY/MN | $65 | 0,00% | 1 | Saham | 30 Juni 2026 |
| Harel Insurance Investments & Financial Services Ltd. | $20 | 0,00% | 198 | Saham | 30 Juni 2026 |
| ROYAL BANK OF CANADA | $0 | 0,00% | 1 | Saham | 30 Juni 2026 |